Back
 

View:
Mini 
BasicThis view is available after user registration.
 
ShortThis view is available when you buy a license.
 
StandardThis view is available when you buy a license.
 
CompleteThis view is available when you buy a license.
 

Rituximab 375 / Lenalidomide 20, Mantle Cell Lymphoma Cycle 2+

Protocol-ID: 324 V1.0 (Mini), RITU375/LENA20 - LENA20 maint., MCL C2+

Indication(s)

  • Mantle Cell Lymphoma; ICD-10 C83.1
The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti.

Valid since: 22.01.2015